co.don AG
Develops personalized cartilage cell transplants for minimally invasive joint repair.
CNW | F
Overview
Corporate Details
- ISIN(s):
- DE000A3E5C08 (+1 more)
- LEI:
- 3912006R73YW0SX1KG21
- Country:
- Germany
- Address:
- Warthestr. 21, 14513 Teltow
- Website:
- https://www.codon.de/en/
- Sector:
- Manufacturing
Description
co.don AG is a biopharmaceutical company specializing in tissue engineering and regenerative medicine. The company focuses on the development, manufacturing, and marketing of autologous cell therapies for the treatment of articular cartilage defects. Its core process involves using a patient's own cartilage cells (chondrocytes) to produce personalized cell transplants, such as spherical cartilage cell implants (spheroids), for the minimally invasive repair of joints. Following an asset purchase in early 2023, the operative business was taken over by an investor and now operates as CO.DON GmbH, a ReLive company, continuing its work in human cell-based therapies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-09-30 00:00 |
Halbjahresfinanzbericht nach WpHG zum Geschäftsjahr vom 01.01.2022 bis zum 30.0…
|
German | 142.4 KB | ||
| 2022-09-29 00:00 |
Hinweis auf Halbjahresfinanzbericht vom 01.01.2022 bis zum 30.06.2022
|
German | 6.4 KB | ||
| 2022-07-11 00:00 |
Jahres- und Konzernabschluss zum Geschäftsjahr vom 01.01.2021 bis zum 31.12.2021
|
German | 1.3 MB | ||
| 2022-07-06 00:00 |
Berichtigung der Veröffentlichung vom 14.06.2022
|
German | 6.4 KB | ||
| 2022-06-14 00:00 |
Berichtigt am 06.07.2022
|
German | 6.4 KB | ||
| 2022-04-29 00:00 |
Hinweis auf Jahresfinanzbericht vom 01.01.2021 bis zum 31.12.2021
|
German | 6.4 KB | ||
| 2021-09-11 00:00 |
CO.DON AG: Mitteilung über Eigengeschäfte von Führungskräften gem. Art. 19 MAR
|
German | 13.9 KB | ||
| 2021-08-30 00:00 |
Halbjahresfinanzbericht
|
German | 148.6 KB | ||
| 2021-05-27 00:00 |
Jahresabschluss zum Geschäftsjahr vom 01.01.2020 bis zum 31.12.2020
|
German | 4.2 KB | ||
| 2021-05-25 00:00 |
Konzernabschluss zum Geschäftsjahr vom 01.01.2020 bis zum 31.12.2020
|
German | 4.2 KB | ||
| 2021-05-22 00:00 |
Ad-hoc-Meldung gemäß Art. 17 MAR in Verbindung mit § 4 Abs. 1 S. 1 Nr. 1a WpAV
|
English | 11.8 KB | ||
| 2020-08-28 00:00 |
Datum:28.08.2020
|
German | 381.2 KB | ||
| 2020-08-24 00:00 |
Datum:24.08.2020
|
German | 12.2 KB | ||
| 2020-07-28 00:00 |
Datum:28.07.2020
|
German | 998.8 KB | ||
| 2020-07-07 00:00 |
Datum:07.07.2020
|
German | 41.3 KB |
Automate Your Workflow. Get a real-time feed of all co.don AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for co.don AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for co.don AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2021-10-21 | Günther, Bernd | Supervisory board | Buy | None | 35.84 EUR |
| 2021-10-20 | Laik, Robin | Board | Other | None | 10,348,300.00 EUR |
| 2021-10-20 | ELBER GmbH | Close relation | Other | None | 10,179,000.00 EUR |
| 2021-10-20 | Rofalski, Volker | Supervisory board | Other | None | 292,500.00 EUR |
| 2021-10-20 | Müller, Dr. Axel | Supervisory board | Other | None | 195,000.00 EUR |
| 2021-10-20 | Laumann, Johannes | Board | Other | None | 131,625.00 EUR |
| 2021-10-20 | Laik, Louisa | Close relation | Other | None | 129,987.00 EUR |
| 2021-10-20 | Laik, Daniel | Close relation | Other | None | 97,500.00 EUR |
| 2021-10-20 | Friedrich, Neela | Close relation | Other | None | 64,993.50 EUR |
| 2021-10-20 | Schleede, Dr. Kristian | Board | Other | None | 29,250.00 EUR |
Peer Companies
